Komori
Techno Ryowa (1965) · InitiativeRestated

Strengthening Sales in the Pharmaceutical-Related Field

First written in FY2016. 23 of 26 entries say "Restated". Latest entry: FY2024.

26entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q3RestatedFY2019-Q2 – FY2021-Q1RestatedFY2021-Q3 – FY20242016: 320162017: 420172018: 320182019: 420192020: 320202021: 220212022: 320222023: 320232024: 12024
Same theme, other companies
Focused Expansion in Healthcare and Welfare, Education, Local Governments and Regional Financial MarketsA theme 15 companies write about · 0 as a headwind · 16 as a tailwind

3 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「医薬品・食品・電子デバイス関連をはじめとする産業設備を中心に引き続きバランスのとれた受注活動を推進」

    医薬品関連を含む産業設備を対象とした受注活動を継続している。
  2. FY2024-Q1RestatedAnnual report

    「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」

    医薬品関連を含む産業設備を対象とした受注活動を継続している。食品・電子デバイス関連も対象分野として併記されている。
  3. FY2023RestatedAnnual report

    「このような状況のなか、当社グループといたしましては、激化する競争環境に対応するため、医薬品・食品・電子デバイス関連をはじめとする産業設備を中心に、引き続きバランスの取れた受注活動を推進するとともに、定年延長やそれに伴う人事制度改正を実施し、人材の確保に努めてまいりました。」

    医薬品・食品・電子デバイス関連を含む産業設備を中心とした受注活動を継続している。
  4. FY2023-Q3RestatedAnnual report

    「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」

    医薬品・食品・電子デバイス関連を含む産業設備を対象とした受注活動を継続している。
  5. FY2023-Q2RestatedAnnual report

    「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」

    医薬品関連を含む産業設備を対象とした受注活動を継続している。食品・電子デバイス関連も対象分野として併記されている。
  6. FY2023-Q1RestatedAnnual report

    「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」

    医薬品関連を含む産業設備を対象とした受注活動を継続している。食品・電子デバイス関連も対象分野として併記されている。
  7. FY2022-Q3RestatedAnnual report

    「Against this backdrop, the Group has implemented measures in line with the basic policies of the three-year medium-term business plan, for which the current consolidated fiscal year is the first year, including continuing to pursue balanced order-taking activities in response to intensifying competition, promoting work-style reform and undertaking ESG initiatives.」

    産業設備工事を含む受注活動の方針を継続しているが、医薬関連分野に関する個別の新施策や進捗は記載されていない。
  8. FY2022-Q2RestatedAnnual report

    「Against this backdrop, the Group has implemented measures in line with the basic policies of the three-year medium-term business plan, for which the current consolidated fiscal year is the first year, including continuing to pursue balanced order-taking activities in response to intensifying competition, promoting work-style reform and undertaking ESG initiatives.」

    医薬品関連を含む産業設備工事での受注方針を継続している。今四半期は産業設備工事の受注高が前年同期比34.9%増加した。
  9. FY2021-Q3RestatedAnnual report

    「Going forward, while continuing to monitor the situation surrounding COVID-19, we will pursue a balanced order portfolio centered on industrial facility projects, including food-related, pharmaceutical-related and electronic-device-related projects, based on the basic policies set out in our three-year medium-term business plan, with the aim of establishing a business foundation less susceptible to economic trends.」

    医薬品関連分野を含む産業設備工事の受注確保方針を、食品・電子デバイス関連を含む対象分野で継続している。
  10. FY2021-Q2RaisedAnnual report

    「Going forward, while continuing to monitor the situation surrounding COVID-19, we will pursue a balanced order portfolio centered on industrial facility projects, including food-related, pharmaceutical-related and electronic-device-related projects, based on the basic policies set out in our three-year medium-term business plan, with the aim of establishing a business foundation less susceptible to economic trends.」

    医薬品関連・食品を中心とする従来の受注対象に、電子デバイス関連を明示的に加え、対象分野を広げている。
  11. FY2021-Q1RestatedAnnual report

    「Going forward, while continuing to monitor the situation surrounding COVID-19, we will pursue a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, based on the basic policies set out in our three-year medium-term business plan, with the aim of establishing a business foundation less susceptible to economic trends.」

    医薬品関連分野を含む産業設備工事を対象に、食品も含めたバランスのとれた受注を推進する方針を継続している。
  12. FY2020-Q3RestatedAnnual report

    「Against this backdrop, the Group has reaffirmed its policy of pursuing a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, without being focused solely on expanding scale, based on the basic policies set out in its three-year medium-term business plan.」

    医薬品関連分野を含む産業設備工事を対象に、食品も含めたバランスのとれた受注を推進する方針を継続している。
  13. FY2020-Q2RestatedAnnual report

    「Against this backdrop, the Group has reaffirmed its policy of pursuing a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, without being focused solely on expanding scale, based on the basic policies set out in its three-year medium-term business plan.」

    医薬品関連分野を含む産業設備工事を対象に、食品も含めたバランスのとれた受注を推進する方針を継続している。
  14. FY2020-Q1RestatedAnnual report

    「Against this backdrop, the Group has reaffirmed its policy of pursuing a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, without being focused solely on expanding scale, based on the basic policies set out in its three-year medium-term business plan.」

    医薬品関連分野を含む産業設備工事を対象に、食品も含めたバランスのとれた受注を推進する方針を継続している。
  15. FY2019RestatedAnnual report

    「このような状況のなか、当社グループといたしましては、中期3か年事業計画の基本方針に基づき、医薬品関連・食品をはじめとする産業設備工事を中心にバランスのとれた受注を推進するとともに、働き方改革の推進やIoT技術の積極的な活用など企業競争力の強化を図ってまいりました。」

    医薬品関連分野を含む産業設備を中心とした受注方針を、食品を含むバランスのとれた受注へ広げた現行方針として継続している。
  16. FY2019-Q3RestatedAnnual report

    「このような状況のなか、当社グループといたしましては、中期3か年事業計画の基本方針に基づき、医薬品関連・食品をはじめとする産業設備を中心にバランスのとれた受注を推進するとともに、働き方改革の推進や IoT技術の積極的な活用など企業競争力の強化を図ってまいりました。」

    医薬品関連・食品をはじめとする産業設備を中心とした受注方針を継続している。
  17. FY2019-Q2RestatedAnnual report

    「このような状況のなか、当社グループといたしましては、中期3か年事業計画の基本方針に基づき、医薬品関連・食品をはじめとする産業設備を中心にバランスのとれた受注を推進することとともに、働き方改革の推進や IoT技術の積極的な活用など企業競争力の強化を図ってまいりました。」

    医薬品関連・食品をはじめとする産業設備を中心としたバランスのとれた受注方針を継続している。
  18. FY2019-Q1RaisedAnnual report

    「このような状況のなか、当社グループといたしましては、中期3か年事業計画の基本方針に基づき、医薬品関連・食品をはじめとする産業設備を中心にバランスのとれた受注を推進することとともに、働き方改革の推進やIoT技術の積極的な活用など企業競争力の強化を図ってまいりました。」

    従来の医薬関連分野中心の受注方針から、食品を含む産業設備全体へ対象範囲を広げ、バランスのとれた受注を推進するとしている。
  19. FY2018-Q3RestatedAnnual report

    「Against this backdrop, the Group focused on securing orders for industrial facility-related projects, particularly in pharmaceutical-related fields, while promoting its end-to-end lifecycle solutions business to reliably capture demand for facility improvement projects.」

    医薬関連分野を中心とした産業設備関連工事の受注確保への注力を継続している。
  20. FY2018-Q2RestatedAnnual report

    「Against this backdrop, the Group focused on securing orders for industrial facility-related projects, particularly in pharmaceutical-related fields, while promoting its end-to-end lifecycle solutions business to reliably capture demand for facility improvement projects.」

    医薬関連分野を中心とした産業設備関連工事の受注確保への注力を継続している。
  21. FY2018-Q1RestatedAnnual report

    「Against this backdrop, the Group focused on securing orders for industrial facility-related projects, particularly in pharmaceutical-related fields, while promoting its end-to-end lifecycle solutions business to reliably capture demand for facility improvement projects.」

    医薬関連分野を中心とした産業設備関連工事の受注確保への注力を継続している。
  22. FY2017RestatedAnnual report

    「We aim to expand our share of the industrial facilities market by increasing consultative sales, particularly in the rapidly growing pharmaceutical manufacturing field.」

    Continues strengthening consultative sales focused on pharmaceutical manufacturing and aims to expand its share of the industrial facilities market.
  23. FY2017-Q3RestatedAnnual report

    「Strengthening consultative sales to industrial facilities, particularly in pharmaceutical-related fields」

    Continues strengthening consultative sales to industrial facilities, particularly in pharmaceutical-related fields. Orders for industrial facility construction rose 5.5% year on year, while revenue increased 27.1%.
  24. FY2017-Q2RestatedAnnual report

    「Against this backdrop, our group has continued to promote its integrated life-cycle solutions business to capture steady demand for the equipment improvement work in which we have traditionally specialized, while strengthening consultative sales for industrial facilities, particularly in pharmaceutical-related fields, and expanding operations in Southeast Asia.」

    Continues strengthening consultative sales to industrial facilities, particularly in pharmaceutical-related fields.
  25. FY2017-Q1RestatedAnnual report

    「We continued initiatives including expanding solution-based sales for industrial facilities, particularly in the pharmaceutical-related field, promoting our integrated lifecycle solutions business to strengthen customer relationships, and expanding the scale of our overseas business over the longer term, thereby working to strengthen our management foundation.」

    Continues consultative sales to industrial facilities, particularly in pharmaceutical-related fields.
  26. FY2016First statedAnnual report

    「We launched an internal project to strengthen sales in the rapidly growing pharmaceutical-related field and have pursued higher orders.」

    Treats the pharmaceutical-related field as a growth area and is using an internal project to expand sales and orders.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Techno Ryowa's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.